WGBA34 Stock Overview
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company.
No risks detected for WGBA34 from our risk checks.
Walgreens Boots Alliance Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$123.96|
|52 Week High||US$161.80|
|52 Week Low||US$101.55|
|1 Month Change||-6.88%|
|3 Month Change||-7.24%|
|1 Year Change||13.56%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||15.08%|
Recent News & Updates
|WGBA34||BR Consumer Retailing||BR Market|
Return vs Industry: WGBA34 exceeded the BR Consumer Retailing industry which returned -26.2% over the past year.
Return vs Market: WGBA34 exceeded the BR Market which returned -12.8% over the past year.
|WGBA34 Average Weekly Movement||4.9%|
|Consumer Retailing Industry Average Movement||5.2%|
|Market Average Movement||6.7%|
|10% most volatile stocks in BR Market||10.5%|
|10% least volatile stocks in BR Market||3.2%|
Stable Share Price: WGBA34 is less volatile than 75% of BR stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: WGBA34's weekly volatility (5%) has been stable over the past year.
About the Company
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.
Walgreens Boots Alliance Fundamentals Summary
|WGBA34 fundamental statistics|
Is WGBA34 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|WGBA34 income statement (TTM)|
|Cost of Revenue||US$104.44b|
Last Reported Earnings
Aug 31, 2021
Next Earnings Date
|Earnings per share (EPS)||2.30|
|Net Profit Margin||1.50%|
How did WGBA34 perform over the long term?See historical performance and comparison
4.4%Current Dividend Yield
Is Walgreens Boots Alliance undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: WGBA34 (R$123.96) is trading below our estimate of fair value (R$363.14)
Significantly Below Fair Value: WGBA34 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: WGBA34 is poor value based on its PE Ratio (19x) compared to the BR Consumer Retailing industry average (18.2x).
PE vs Market: WGBA34 is poor value based on its PE Ratio (19x) compared to the BR market (9.9x).
Price to Earnings Growth Ratio
PEG Ratio: WGBA34 is poor value based on its PEG Ratio (1.2x)
Price to Book Ratio
PB vs Industry: WGBA34 is good value based on its PB Ratio (1.6x) compared to the BR Consumer Retailing industry average (1.7x).
How is Walgreens Boots Alliance forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: WGBA34's forecast earnings growth (16.4% per year) is above the savings rate (9.1%).
Earnings vs Market: WGBA34's earnings (16.4% per year) are forecast to grow faster than the BR market (9.1% per year).
High Growth Earnings: WGBA34's earnings are forecast to grow, but not significantly.
Revenue vs Market: WGBA34's revenue (2.7% per year) is forecast to grow slower than the BR market (7.4% per year).
High Growth Revenue: WGBA34's revenue (2.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: WGBA34's Return on Equity is forecast to be low in 3 years time (18.1%).
How has Walgreens Boots Alliance performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: WGBA34 has high quality earnings.
Growing Profit Margin: WGBA34's current net profit margins (1.5%) are higher than last year (0.1%).
Past Earnings Growth Analysis
Earnings Trend: WGBA34's earnings have declined by 24.9% per year over the past 5 years.
Accelerating Growth: WGBA34's earnings growth over the past year (1014%) exceeds its 5-year average (-24.9% per year).
Earnings vs Industry: WGBA34 earnings growth over the past year (1014%) exceeded the Consumer Retailing industry 60.5%.
Return on Equity
High ROE: WGBA34's Return on Equity (8.1%) is considered low.
How is Walgreens Boots Alliance's financial position?
Financial Position Analysis
Short Term Liabilities: WGBA34's short term assets ($15.8B) do not cover its short term liabilities ($22.1B).
Long Term Liabilities: WGBA34's short term assets ($15.8B) do not cover its long term liabilities ($35.1B).
Debt to Equity History and Analysis
Debt Level: WGBA34's net debt to equity ratio (32.4%) is considered satisfactory.
Reducing Debt: WGBA34's debt to equity ratio has reduced from 37.4% to 37.3% over the past 5 years.
Debt Coverage: WGBA34's debt is well covered by operating cash flow (61.6%).
Interest Coverage: WGBA34's interest payments on its debt are well covered by EBIT (8.1x coverage).
What is Walgreens Boots Alliance current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: WGBA34's dividend (4.37%) is higher than the bottom 25% of dividend payers in the BR market (1.29%).
High Dividend: WGBA34's dividend (4.37%) is low compared to the top 25% of dividend payers in the BR market (5.83%).
Stability and Growth of Payments
Stable Dividend: WGBA34's dividends per share have been stable in the past 10 years.
Growing Dividend: WGBA34's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: At its current payout ratio (81.5%), WGBA34's payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: WGBA34's dividends in 3 years are forecast to be well covered by earnings (38.5% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Roz Brewer (59 yo)
Ms. Rosalind Gates Brewer, also known as Roz, has been Chief Executive Officer and Director at Walgreens Boots Alliance, Inc. since March 15, 2021. She serves as a Member of The Diversified Advisory Group...
Experienced Management: WGBA34's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Experienced Board: WGBA34's board of directors are considered experienced (8.1 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Walgreens Boots Alliance, Inc.'s employee growth, exchange listings and data sources
- Name: Walgreens Boots Alliance, Inc.
- Ticker: WGBA34
- Exchange: BOVESPA
- Founded: 1901
- Industry: Drug Retail
- Sector: Consumer Retailing
- Market Cap: US$37.845b
- Listing Market Cap: US$212.838b
- Shares outstanding: 865.61m
- Website: https://www.walgreensbootsalliance.com
Number of Employees
- Walgreens Boots Alliance, Inc.
- 108 Wilmot Road
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/12/02 22:58|
|End of Day Share Price||2021/12/02 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.